Sign up to save your podcasts
Or
Share Editor's Special Episode: Future Directions in MPN Treatment with Dr. Hobbs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Editor's Special Episode: Future Directions in MPN Treatment with Dr. Hobbs
Dr. Hobbs joins the podcast to discuss the latest advances in myeloproliferative neoplasms (MPNs), including ropeginterferon and the VERIFY trial of rusfertide in polycythemia vera. He highlights key efficacy and safety data, unmet needs in essential thrombocythemia and myelofibrosis, and the next wave of clinical trials to watch.
View all episodes
By Rahul Banerjee, MD
4.8
2626 ratings
Dr. Hobbs joins the podcast to discuss the latest advances in myeloproliferative neoplasms (MPNs), including ropeginterferon and the VERIFY trial of rusfertide in polycythemia vera. He highlights key efficacy and safety data, unmet needs in essential thrombocythemia and myelofibrosis, and the next wave of clinical trials to watch.
More shows like The HemOnc Pulse
View all
JAMA Editors' Summary
138 Listeners
Research To Practice | Oncology Videos
116 Listeners
Making Sense with Sam Harris
26,355 Listeners
The Hematologist
28 Listeners
OncoPharm
184 Listeners
VJHemOnc Podcast
2 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Blood Podcast
54 Listeners
The Curious Clinicians
372 Listeners
Healthcare Unfiltered
136 Listeners
ASTCT Talks
9 Listeners
WolverHeme Happy Hour
29 Listeners
Two Onc Docs
185 Listeners
Blood Cancer Talks
49 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
43 Listeners